title: Rationale for the use of calcitonin in postmenopausal osteoporosis.
abstract: Calcitonin has been used in the prevention and treatment of osteoporosis already for several years. The results have been promising. Especially patients with high-turnover osteoporosis respond satisfactorily to the treatment. In the immediate postmenopausal period calcitonin should be considered appropriate if estrogens are either contraindicated or refused by the patient.
authors.affiliation: Washington University School of Medicine, Jewish Hospital, St. Louis, Mo.
authors.forename: L V
authors.initials: LV
authors.lastname: Avioli
mesh_terms: D002116:Calcitonin / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008593:Menopause; D010024:Osteoporosis / Q000188:drug therapy*
chemical_list: D002116:Calcitonin